Logo image of TIC

ACUREN CORPORATION (TIC) Stock Fundamental Analysis

NYSE:TIC - New York Stock Exchange, Inc. - US00510N1028 - Common Stock - Currency: USD

10.5  -0.2 (-1.87%)

After market: 10.25 -0.25 (-2.38%)

Fundamental Rating

3

We assign a fundamental rating of 3 out of 10 to TIC. TIC was compared to 81 industry peers in the Professional Services industry. While TIC has a great health rating, there are worries on its profitability. TIC does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

TIC had positive earnings in the past year.
TIC had a positive operating cash flow in the past year.
TIC Yearly Net Income VS EBIT VS OCF VS FCFTIC Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2022 2023 0 5M 10M

1.2 Ratios

Looking at the Return On Assets, with a value of 2.48%, TIC is in line with its industry, outperforming 48.15% of the companies in the same industry.
TIC has a Return On Equity (2.48%) which is comparable to the rest of the industry.
Industry RankSector Rank
ROA 2.48%
ROE 2.48%
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
TIC Yearly ROA, ROE, ROICTIC Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2022 2023 0 0.5 1 1.5 2

1.3 Margins

TIC does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
TIC Yearly Profit, Operating, Gross MarginsTIC Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2022 2023

More info and screens

7

2. Health

2.1 Basic Checks

TIC has less shares outstanding than it did 1 year ago.
There is no outstanding debt for TIC. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
TIC Yearly Shares OutstandingTIC Yearly Shares OutstandingYearly Shares Outstanding 2022 2023 10M 20M 30M 40M 50M
TIC Yearly Total Debt VS Total AssetsTIC Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2022 2023 100M 200M 300M 400M 500M

2.2 Solvency

There is no outstanding debt for TIC. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z N/A
ROIC/WACCN/A
WACCN/A
TIC Yearly LT Debt VS Equity VS FCFTIC Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2022 2023 100M 200M 300M 400M 500M

2.3 Liquidity

A Current Ratio of 886.16 indicates that TIC has no problem at all paying its short term obligations.
Looking at the Current ratio, with a value of 886.16, TIC belongs to the top of the industry, outperforming 100.00% of the companies in the same industry.
A Quick Ratio of 886.16 indicates that TIC has no problem at all paying its short term obligations.
Looking at the Quick ratio, with a value of 886.16, TIC belongs to the top of the industry, outperforming 100.00% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 886.16
Quick Ratio 886.16
TIC Yearly Current Assets VS Current LiabilitesTIC Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2023 100M 200M 300M 400M 500M

More info and screens

1

3. Growth

3.1 Past

EPS 1Y (TTM)N/A
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%N/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

The Earnings Per Share is expected to grow by 40.05% on average over the next years. This is a very strong growth
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2Y31.28%
EPS Next 3Y28.14%
EPS Next 5Y40.05%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
TIC Yearly Revenue VS EstimatesTIC Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2025 2026 2027 200M 400M 600M 800M 1B
TIC Yearly EPS VS EstimatesTIC Yearly EPS VS EstimatesYearly EPS VS Estimates 2025 2026 2027 0.2 0.4 0.6 0.8

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

TIC is valuated quite expensively with a Price/Earnings ratio of 42.00.
71.60% of the companies in the same industry are cheaper than TIC, based on the Price/Earnings ratio.
Compared to an average S&P500 Price/Earnings ratio of 26.25, TIC is valued quite expensively.
Industry RankSector Rank
PE 42
Fwd PE N/A
TIC Price Earnings VS Forward Price EarningsTIC Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

Compared to the rest of the industry, the Price/Free Cash Flow ratio of TIC indicates a slightly more expensive valuation: TIC is more expensive than 67.90% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 157.51
EV/EBITDA N/A
TIC Per share dataTIC EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 1 2 3 4

4.3 Compensation for Growth

A more expensive valuation may be justified as TIC's earnings are expected to grow with 28.14% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y31.28%
EPS Next 3Y28.14%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for TIC!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

ACUREN CORPORATION

NYSE:TIC (5/30/2025, 8:04:01 PM)

After market: 10.25 -0.25 (-2.38%)

10.5

-0.2 (-1.87%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCommercial & Professional Services
GICS IndustryProfessional Services
Earnings (Last)05-15 2025-05-15/bmo
Earnings (Next)N/A N/A
Inst Owners39.97%
Inst Owner ChangeN/A
Ins Owners15.9%
Ins Owner Change0%
Market Cap1.28B
Analysts82.86
Price Target14.28 (36%)
Short Float %0.06%
Short Ratio0.28
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 42
Fwd PE N/A
P/S N/A
P/FCF 157.51
P/OCF 157.51
P/B 2.31
P/tB 2.31
EV/EBITDA N/A
EPS(TTM)0.25
EY2.38%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)0.07
FCFY0.63%
OCF(TTM)0.07
OCFY0.63%
SpSN/A
BVpS4.55
TBVpS4.55
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 2.48%
ROE 2.48%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-ScoreN/A
Asset TurnoverN/A
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality 58.95%
Current Ratio 886.16
Quick Ratio 886.16
Altman-Z N/A
F-ScoreN/A
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)N/A
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%N/A
EPS Next YN/A
EPS Next 2Y31.28%
EPS Next 3Y28.14%
EPS Next 5Y40.05%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1YN/A
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3Y445.18%
EBIT Next 5Y259.94%
FCF growth 1YN/A
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1YN/A
OCF growth 3YN/A
OCF growth 5YN/A